What is the maximum amount I can increase my 70/30 (Novolin or Humulin) insulin dose by?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Dose Increase for 70/30 Insulin

Increase your 70/30 insulin by 2 units when 50% or more of your fasting blood glucose values exceed your target goal of 90-150 mg/dL over a one-week period. 1

Standard Titration Protocol

The American Diabetes Association provides clear guidance for adjusting premixed 70/30 insulin:

  • Assess fasting glucose values over 1 week to determine if adjustment is needed 2, 1
  • Increase by 2 units if ≥50% of fasting fingerstick values are above goal (90-150 mg/dL) 2, 1
  • Decrease by 2 units if >2 fasting values per week are <80 mg/dL to prevent hypoglycemia 2, 1
  • Reassess every 2 weeks and repeat the adjustment process based on glucose patterns 1, 3

Critical Safety Thresholds

When your total daily dose of 70/30 insulin exceeds 0.5 units/kg/day, you should consider switching to a different insulin regimen rather than continuing to escalate the dose. 3 This threshold represents a point where:

  • Further dose increases carry substantially higher hypoglycemia risk without proportional benefit 3
  • Alternative strategies (adding other medications or switching to basal-bolus insulin) become more appropriate 3
  • The fixed ratio of 70/30 may no longer provide optimal glucose control 3

Practical Dosing Context

For patients with type 2 diabetes on 70/30 insulin:

  • Total daily requirements commonly reach ≥1 unit/kg/day or higher, which is substantially more than type 1 diabetes requirements 3
  • Each dose adjustment should be 2 units - not more, not less - to maintain safety while achieving glycemic targets 2, 1
  • Never adjust more frequently than weekly to allow adequate time to assess the effect of the change 2, 1

When to Stop Escalating and Consider Alternatives

Do not continue indefinitely increasing your 70/30 dose if your A1C remains above target. 3 This represents therapeutic inertia and increases complications. Instead, consider:

  • Adding an SGLT-2 inhibitor or GLP-1 receptor agonist to improve control while reducing insulin requirements 3
  • Transitioning to basal insulin plus GLP-1 receptor agonist, which provides potent glucose-lowering with less weight gain and hypoglycemia 3
  • Converting to basal-bolus regimen for patients needing more precise dosing control 3

Common Pitfalls to Avoid

  • Never increase by more than 2 units at a time - larger adjustments increase hypoglycemia risk without evidence of benefit 2, 1
  • Do not adjust based on a single glucose reading - you need patterns over at least one week 2, 1
  • Avoid skipping meals when on 70/30 insulin, as the fixed insulin action profile requires consistent meal timing to prevent hypoglycemia 1
  • Always carry quick-acting carbohydrates as physical activity may cause hypoglycemia depending on timing 1

Hypoglycemia Management

If hypoglycemia occurs:

  • Determine the cause (missed meal, increased activity, incorrect dose) 1
  • If no clear reason exists, lower the corresponding dose by 10-20% immediately 1
  • Reassess your overall regimen if hypoglycemia becomes recurrent 1

References

Guideline

Titrating Premixed Insulin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Insulin Dosing Guidelines for Novolin 70/30

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.